Translational Development Acquisition Corp. (TDAC)
NASDAQ: TDAC · Real-Time Price · USD
10.08
0.00 (0.00%)
At close: Apr 1, 2025, 4:00 PM
10.10
+0.02 (0.17%)
After-hours: Apr 1, 2025, 4:02 PM EDT
Company Description
Translational Development Acquisition Corp. intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
The company was incorporated in 2022 and is based in New York, New York.
Translational Development Acquisition Corp.
| Country | United States |
| Founded | 2022 |
| IPO Date | Dec 23, 2024 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Michael M. Hoffman |
Contact Details
Address: 52 E. 83rd Street New York, New York 10028 United States | |
| Phone | 917 979 3072 |
| Website | translational-development.com |
Stock Details
| Ticker Symbol | TDAC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001926599 |
| CUSIP Number | 89615T106 |
| ISIN Number | US89615T1060 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Michael M. B. Hoffman J.D. | Chairman of the Board and Chief Executive Officer |
| Avi C. Das | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 31, 2025 | 10-K | Annual Report |
| Feb 14, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G | Filing |
| Feb 14, 2025 | SCHEDULE 13G | Filing |
| Jan 29, 2025 | SCHEDULE 13G | Filing |
| Dec 31, 2024 | 8-K | Current Report |
| Dec 27, 2024 | 8-K | Current Report |
| Dec 23, 2024 | 424B4 | Prospectus |
| Dec 20, 2024 | EFFECT | Notice of Effectiveness |
| Dec 20, 2024 | CERT | Certification by an exchange approving securities for listing |